|
|
Volumn 56, Issue SUPPL. 1, 1998, Pages 25-31
|
|
Extending therapy options in treating lipid disorders. A clinical review of cerivastatin, a novel HMG-CoA reductase inhibitor
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AMINOTRANSFERASE;
ATORVASTATIN;
CERIVASTATIN;
CHOLESTEROL;
FLUINDOSTATIN;
HIGH DENSITY LIPOPROTEIN CHOLESTEROL;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
LOW DENSITY LIPOPROTEIN CHOLESTEROL;
MEVINOLIN;
PRAVASTATIN;
SIMVASTATIN;
TRIACYLGLYCEROL;
CHOLESTEROL BLOOD LEVEL;
CLINICAL TRIAL;
CONFERENCE PAPER;
DOSE RESPONSE;
DRUG EFFICACY;
DRUG POTENCY;
DRUG TOLERABILITY;
HUMAN;
HYPERCHOLESTEROLEMIA;
SIDE EFFECT;
TRIACYLGLYCEROL BLOOD LEVEL;
|
|
EID: 0031680609
PISSN: 00126667
EISSN: None
Source Type: Journal
DOI: 10.2165/00003495-199856001-00004 Document Type: Conference Paper |
|
Times cited : (25)
|
|
References (25)
|
